Clinical Trial Update: Hybrid Sirolimus-eluting Versus Everolimus-eluting Stents for Total Coronary Occlusions [Phase 3]

View source ↗

Summary

Phase 3 trial comparing a hybrid sirolimus-eluting stent with an everolimus-eluting stent for total coronary occlusions is being conducted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Coronary Stenosis

Drugs mentioned

• Everolimus-eluting stent (everolimus-eluting stent)
• Sirolimus-eluting stent (sirolimus-eluting stent)

Snippet

Sponsor: R&D Cardiologie | Conditions: Coronary Artery Disease, Coronary Disease | Phase 3 | Status: UNKNOWN